PRDX4 and cholestasis: Therefore, in the present study, PRDX4 may have attenuated cholestasis-induced liver injury by reducing extracellular oxidant stress and mitochondrial dysfunction, thereby suppressing the release of inflammatory cytokines and neutrophil infiltration.